8-KEarnings & ResultsExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (Mar 3, 2011)

Filed March 3, 2011For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on March 3, 2011, primarily to report its financial results for the year ended December 31, 2010, and to furnish a press release containing this information. This filing serves as an update for investors on the company's operational and financial performance during the 2010 fiscal year. The key takeaway for investors is the disclosure of financial results, which would typically include revenue, profitability, and other key performance indicators relevant to DexCom's business operations in the continuous glucose monitoring sector. The press release, incorporated by reference as Exhibit 99.01, contains the specific financial data. While the 8-K itself does not detail these figures, it directs stakeholders to the press release for a comprehensive understanding of the company's financial condition and results of operations for the full year 2010. Investors should review Exhibit 99.01 for the actual financial figures and any management commentary provided therein.

Key Highlights

  • 1DexCom, Inc. filed an 8-K on March 3, 2011, reporting on its financial results.
  • 2The report specifically covers the fiscal year ended December 31, 2010.
  • 3The financial results and related information are presented in a press release furnished as Exhibit 99.01.
  • 4This filing is made under Item 2.02 (Results of Operations and Financial Condition).
  • 5The information is furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
  • 6The press release serves as the primary source for detailed financial performance data for 2010.

Frequently Asked Questions

The main purpose of this 8-K filing by DexCom, Inc. on March 3, 2011, is to announce and provide access to its financial results for the fiscal year ended December 31, 2010. It includes a press release that contains the detailed financial information.

The specific financial results for DexCom for the year ended December 31, 2010, are detailed in the press release furnished as Exhibit 99.01 to this 8-K filing. Investors should refer to this exhibit for the comprehensive financial data.

No, the information provided in this Item 2.02 filing, including the furnished press release, is specifically stated as being 'furnished' and not 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This means it does not carry the same legal implications or liabilities as a formally filed document under that section.

Based on the context of financial reporting and industry focus, DexCom is understood to be a company operating in the medical device or healthcare technology sector, likely focusing on diabetes management given the common association with continuous glucose monitoring technology.